摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

7-amino-3-tert-butyl-4-oxo-4,6-dihydropyrazolo[5,1-c][1,2,4]triazine-8-carbonitrile | 522624-22-2

中文名称
——
中文别名
——
英文名称
7-amino-3-tert-butyl-4-oxo-4,6-dihydropyrazolo[5,1-c][1,2,4]triazine-8-carbonitrile
英文别名
7-Amino-3-tert-butyl-4-oxo-1,4-dihydropyrazolo[5,1-c][1,2,4]triazine-8-carbonitrile;7-amino-3-tert-butyl-4-oxo-6H-pyrazolo[5,1-c][1,2,4]triazine-8-carbonitrile
7-amino-3-tert-butyl-4-oxo-4,6-dihydropyrazolo[5,1-c][1,2,4]triazine-8-carbonitrile化学式
CAS
522624-22-2
化学式
C10H12N6O
mdl
——
分子量
232.245
InChiKey
YXZDGVORGYTJJL-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.1
  • 重原子数:
    17
  • 可旋转键数:
    1
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.4
  • 拓扑面积:
    107
  • 氢给体数:
    2
  • 氢受体数:
    6

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    7-amino-3-tert-butyl-4-oxo-4,6-dihydropyrazolo[5,1-c][1,2,4]triazine-8-carbonitrile 在 potassium hydroxide 作用下, 以 异丙醇 为溶剂, 反应 0.33h, 以90%的产率得到7-amino-3-tert-butyl-4-oxo-4,6-dihydropyrazolo[5,1-c][1,2,4]triazine-8-carboxamide
    参考文献:
    名称:
    Reaction of 7-amino-3-tert-butyl-4-oxo-4,6-dihydropyrazolo[5,1-c]triazine-8-carboxamide with carbonyl compounds
    摘要:
    DOI:
    10.1134/s1070363213010337
  • 作为产物:
    描述:
    嗪草酮丙二腈吡啶 作用下, 以84%的产率得到7-amino-3-tert-butyl-4-oxo-4,6-dihydropyrazolo[5,1-c][1,2,4]triazine-8-carbonitrile
    参考文献:
    名称:
    8-R-7-氨基-3-叔丁基吡唑并-[5,1-c] [1,2,4]三嗪-4(6 H)-ones衍生物的合成
    摘要:
    通过与酮,酸酐,苯甲酰氯煮沸,分离出8-R-7-氨基-3-叔丁基吡唑并[5,1- c ] [1,2,4]三嗪-4(6 H)-ones衍生物。和肼。化合物的结构由元素分析,IR,1 H NMR和质谱数据确定。
    DOI:
    10.1007/s10593-012-0904-7
点击查看最新优质反应信息

文献信息

  • Diastereoselective synthesis of 3-tert-butyl-3,4-dihydropyrazolo[5,1-c][1,2,4]triazine-3,4-diyl dicarboxylates
    作者:Sergey M. Ivanov、Andrey S. Dmitrenok、Konstantin A. Lyssenko
    DOI:10.1016/j.tetlet.2019.151109
    日期:2019.10
    2-pyrazolo[5,1-c][1,2,4]triazines (R1 = H, Br; R2 = Me, n-Bu) with N-bromosuccinimide in the presence of R3CO2H (R3 = Me, t-Bu, Ph) afforded novel diastereomerically pure 3-tert-butyl-7-R1-8-R2-3,4-dihydropyrazolo[5,1-c][1,2,4]triazine-3,4-diyl dicarboxylates. The structures of the isolated products were established on the basis of IR, 1H, 13C, 2D NOESY NMR, high resolution mass spectrometry and X-ray
    的反应中的3-叔丁基-7- [R 1 -8- - [R 2 -吡唑并[5,1- c ^ ] [1,2,4]三嗪(R 1  = H,溴; R 2  = Me中,Ñ -在R 3 CO 2 H(R 3  = Me,t -Bu,Ph)存在下用N-溴琥珀酰亚胺(Bu)提供新的非对映异构纯3-叔丁基-7- R 1 -8- R 2 -3,4 -二氢吡唑并[5,1- c] [1,2,4]三嗪-3,4-二烷基二羧酸酯。分离的产物的结构基于IR,1 H,13 C,2D NOESY NMR,高分辨率质谱和X射线单晶分析建立。还讨论了所观察到的区域选择性和立体选择性的空间和机理起源。
  • 7-tert-butyl[1,2,4]triazino[4',3':1,5]pyrazolo[3,4-d][1,2,3]triazine-4,8(3Н,9Н)-dione in nucleophilic substitution reactions
    作者:L. M. Mironovich、D. V. Shcherbinin
    DOI:10.1134/s1070428016020238
    日期:2016.2
    triazine fragment exhibit various kinds of bioactivity: antibacterial, antitumor action [1, 2]. We formerly investigated the reactivity of substituted pyrazolo[5,1-с][1,2,4]triazines [3–7]. In extension of these studies we report here on the reactions of [1,2,4]triazino[4',3':1,5]pyrazolo[3,4-d][1,2,3]triazines at the nitrogen atom of the heterocycle and at the mercapto group.
    在其结构中含有三嗪片段的稠合杂环化合物表现出多种生物活性:抗菌、抗肿瘤作用 [1, 2]。我们以前研究了取代的吡唑并[5,1-с][1,2,4]三嗪[3-7]的反应性。作为这些研究的延伸,我们在此报告了 [1,2,4]三嗪[4',3':1,5]吡唑并[3,4-d][1,2,3]三嗪在氮中的反应杂环原子和巯基。
  • Synthesis of new 4-oxo-1,2,3,4-tetrahydropyrazolo[5,1-с][1,2,4]triazines
    作者:S. M. Ivanov、L. M. Mironovich、L. A. Rodinovskaya、A. M. Shestopalov
    DOI:10.1007/s11172-018-2244-y
    日期:2018.8
    6-dihydropyrazolo[5,1-c][1,2,4]triazine-8-carbonitrile led to N1-substituted derivative, which upon treatment with NaH and MeI in DMF was converted to 1-benzyl-3-tert-butyl-7-dimethylamino-4-oxo-1,4-dihydropyrazolo-[5,1-c][1,2,4]triazine-8-carbonitrile. The latter reacted with Grignard reagents to give high yields of new 3-tert-butyl-3-R-4-oxo-1,2,3,4-tetrahydropyrazolo[5,1-c][1,2,4]triazines (R = Alk, Ph)
    7-amino-3-tert-butyl-4-oxo-4,6-dihydropyrazolo[5,1-c][1,2,4]triazine-8-carbonitrile 的烷基化导致 N1-取代的衍生物,在处理后用 NaH 和 MeI 在 DMF 中转化为 1-benzyl-3-tert-butyl-7-dimethylamino-4-oxo-1,4-dihydropyrazolo-[5,1-c][1,2,4]triazine-8 -腈。后者与格氏试剂反应得到高产率的新 3-叔丁基-3-R-4-氧代-1,2,3,4-四氢吡唑并[5,1-c][1,2,4]三嗪(R = Alk, Ph)。研究了反应过程和条件,讨论了产物的光谱特性。
  • Synthesis of new pyrido[2′,3′:3,4]pyrazolo[5,1-c]-[1,2,4]triazin-4(6H)-one derivatives
    作者:S. M. Ivanov、L. M. Mironovich、L. A. Rodinovskaya、A. M. Shestopalov
    DOI:10.1007/s11172-017-1865-x
    日期:2017.6
    New pyrido[2′,3′:3,4]pyrazolo[5,1-c][1,2,4]triazin-4(6H)-one derivatives were synthesized from accessible 1,2,4-triazine and pyrazolo[5,1-c][1,2,4]triazine derivatives. Specific features of the reactions were studied and spectral characteristics of the compounds are reported.
    由可接近的1,2,4-三嗪和吡唑并合成新的吡啶并[2',3':3,4]吡唑并[5,1-c][1,2,4]triazin-4(6H)-one衍生物[5,1-c][1,2,4]三嗪衍生物。研究了反应的具体特征并报告了化合物的光谱特征。
  • Synthesis of 8-R-7-amino-3-tert-butylpyrazolo- [5,1-c][1,2,4]triazin-4(6H)-ones derivatives
    作者:L. M. Mironovich、M. V. Kostina
    DOI:10.1007/s10593-012-0904-7
    日期:2012.1
    8-R-7-Amino-3-tert-butylpyrazolo[5,1-c][1,2,4]triazin-4(6H)-ones derivatives were isolated by boiling them with ketones, anhydrides, benzoyl chloride, and hydrazine. The structures of the compounds were established from data of elemental analysis, IR, 1H NMR, and mass spectrometry.
    通过与酮,酸酐,苯甲酰氯煮沸,分离出8-R-7-氨基-3-叔丁基吡唑并[5,1- c ] [1,2,4]三嗪-4(6 H)-ones衍生物。和肼。化合物的结构由元素分析,IR,1 H NMR和质谱数据确定。
查看更多

同类化合物

酪氨酸,2-甲氧基-O-甲基- 达美司特 百里酚-6-磺化三(2-羟基乙基)铵 吡唑并[1,5-a][1,3,5]噻嗪-4(3H)-酮 吡唑并[1,5-a][1,3,5]三嗪-2,4-二胺 吡唑并[1,5-D][1,2,4]三嗪酮 吡唑并[1,5-A]-1,3,5-三嗪-2,4(1H,3H)-二酮 N4-(1,1-二甲基乙基)-7-甲基吡唑并(1,5-a)-1,3,5-三嗪-2,4-二胺盐酸盐 N'-甲酰基-4-氨基吡唑并[5,1-c][1,2,4]三嗪-3-甲酰肼 8-苄基-2-甲基-4-(N-甲基氨基)吡唑并[1,5-a]-1,3,5-三嗪 8-溴-4-氯-2-(甲基硫代)吡唑并[1,5-a][1,3,5]三嗪 7-甲基-6H-吡唑并[4,5-e][1,2,3]三嗪-4-酮 7-甲基-1,7-二氢-4H-吡唑并[3,4-d][1,2,3]三嗪-4-酮2-氧化物 7-(叔丁基)吡唑并[1,5-a][1,3,5]三嗪-4(3H)-酮 5,6-二氢吡唑并[1,5-d][1,2,4]三嗪-4,7-二酮 4-甲氧基吡唑并[1,5-a][1,3,5]三嗪 4-氯-2-(甲硫基)吡唑并[1,5-a][1,3,5]三嗪 4-氨基-7-甲基吡唑并[5,1-C][1,2,4]三嗪-3-甲腈 4,7-二甲基吡唑并[5,1-c][1,2,4]三嗪-3-羧酸乙酯 4,7-二甲基吡唑并[5,1-C][1,2,4]三嗪-3-羧酸 4,6-二氢-6-(碘乙酰基)-3-甲基-4-亚甲基吡唑并[5,1-c][1,2,4]三嗪 3-甲氧基-2H-吡唑并[4,3-e][1,2,4]三嗪 3-(1,1-二甲基乙基)-7-(5-甲基-3-异恶唑基)-2-[(1-甲基-1H-1,2,4-三唑-5-基)甲氧基]吡唑并[1,5-d][1,2,4]三嗪 3,4-二甲基吡唑并[5,1-c][1,2,4]三嗪 2-甲基吡唑并[1,5-d][1,2,4]三嗪-4(5H)-酮 2-甲基-4-(N-甲基氨基)-8-[(2-噻吩基)甲基]吡唑并[1,5-a]-1,3,5-三嗪 2-Thi氧代-2,3-二氢吡唑并[1,5-a][1,3,5]噻嗪-4(1H)-酮 2-(甲基硫代)吡唑并[1,5-a][1,3,5]噻嗪-4(3H)-酮 2,4-二氨基-吡唑并(1,5-a)-S-三嗪盐酸盐半水合物 2,4-二(甲基氨基)-7-甲基吡唑并(1,5-a)-S-三嗪 1-(4,7-二甲基吡唑并[5,1-c][1,2,4]三氮杂-3-基)-1-乙酮 4-(2,4-dichlorophenyl)-8-(3-pentyl)-7-ethyl-2-methyl-pyrazolo[1,5-a]-1,3,5-triazine 2-(4-tert-butylphenyl)-4-({3-[(2,3-dihydro-1H-inden-2-yl)amino]-2,2-difluoropropyl}amino)-6H,7H-pyrazolo[1,5-a][1,3,5]triazin-7-one 2-(4-tert-butylphenyl)-4-{[3-(dimethylamino)propyl]amino}-8-[(6-methylpyridin-3-yl)methyl]-6H,7H-pyrazolo[1,5-a][1,3,5]triazin-7-one 4-methyl-N-(1-methyl-1-phenylethyl)-2-phenyl-1,2,3,4-tetrahydropyrazolo[5,1-c][1,2,4]triazine-8-carboxamide 2,4-diphenyl-pyrazolo[1,5-a][1,3,5]triazine 3H-8-carbonitrile-2-(5-chlorouracil-6-methylthio)pyrazolo[1,5-a][1,3,5]triazin-4-one 3H-2-(5-chlorouracil-6-methylthio)-7-tert-butylpyrazolo[1,5-a][1,3,5]triazin-4-one 3H-2-(5-chlorouracil-6-methylthio)-7-methylpyrazolo[1,5-a][1,3,5]triazin-4-one 3H-8-carboxylic acid ethyl ester 2-(5-chlorouracil-6-methylthio)pyrazolo[1,5-a][1,3,5]triazin-4-one 3H-2-(5-chlorouracil-6-methylthio)-7-trifluoromethylpyrazolo[1,5-a][1,3,5]triazin-4-one 3H-2-(5-chlorouracil-6-methylthio)-8-methylpyrazolo[1,5-a][1,3,5]triazin-4-one 3H-2-(5-chlorouracil-6-methylthio)pyrazolo[1,5-a][1,3,5]triazin-4-one 3H-2-(5-chlorouracil-6-methylthio)-8-iodopyrazolo[1,5-a][1,3,5]triazin-4-one 3H-8-chloro-2-(5-chlorouracil-6-methylthio)pyrazolo[1,5-a][1,3,5]triazin-4-one 3H-8-bromo-2-(5-chlorouracil-6-methylthio)pyrazolo[1,5-a][1,3,5]triazin-4-one 6-[4-(1-hydroxy-1-methylethyl)phenyl]-2-methyl-5H-1,5,7,7a-tetraazainden-4-one Pyrazolo<3,2-f><1,2,4>triazin-4(3H)-on methyl 3,7-dimethyl-4-oxo-4,6-dihydro-pyrazolo[5,1-c][1,2,4]triazine-8-carboxylate 2-(4-tert-butylphenyl)-4-{[3-(4-chloro-3-methylphenoxy)propyl]sulfanyl}-6H,7H-pyrazolo[1,5-a] [1,3,5]triazin-7-one